
Akumin AKU
Quartalsbericht 2023-Q3
hinzugefügt 12.12.2023
Akumin Kurshistorie 2011-2026 | AKU
Kurshistorie Jährlich Akumin
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.84 | 1.08 | 3.64 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.64 | 0.84 | 1.85 |
Kurshistorie anderer Aktien in der Diagnostik & Forschung
| Name | Kurshistorie | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.38 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
8.43 | $ 19.52 | 8.84 % | $ 210 M | ||
|
Agilent Technologies
A
|
139 | $ 120.67 | 2.69 % | $ 36.7 B | ||
|
Check-Cap Ltd.
CHEK
|
0.74 | - | - | $ 9.42 M | ||
|
Aspira Women's Health
AWH
|
0.39 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
0.35 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
0.39 | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
1.3 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
18.6 | $ 17.52 | 4.1 % | $ 934 M | ||
|
Exact Sciences Corporation
EXAS
|
103 | - | - | $ 19.8 B | ||
|
Enzo Biochem
ENZ
|
1.13 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
4.4 | $ 1.45 | -0.34 % | $ 1.93 M | ||
|
Accelerate Diagnostics
AXDX
|
0.49 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
25.5 | $ 24.41 | 3.74 % | $ 678 M | ||
|
Global Cord Blood Corporation
CO
|
2.5 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
1.44 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
0.87 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
155 | $ 180.56 | 1.24 % | $ 8.95 B | ||
|
Medpace Holdings
MEDP
|
449 | $ 515.92 | 2.93 % | $ 14.9 B | ||
|
Interpace Biosciences
IDXG
|
1.66 | $ 2.2 | - | $ 9.73 M | ||
|
Danaher Corporation
DHR
|
210 | $ 198.27 | 1.23 % | $ 141 B | ||
|
Heska Corporation
HSKA
|
81.6 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.36 | - | -20.0 % | $ 1.06 M | ||
|
Myriad Genetics
MYGN
|
4.42 | $ 4.83 | 5.12 % | $ 447 M | ||
|
NeoGenomics
NEO
|
11.6 | $ 8.27 | 3.31 % | $ 1.06 B | ||
|
Illumina
ILMN
|
103 | $ 129.57 | 2.06 % | $ 20.6 B | ||
|
Natera
NTRA
|
53.9 | $ 212.99 | 5.49 % | $ 21 B | ||
|
Fulgent Genetics
FLGT
|
15.4 | $ 15.64 | 2.22 % | $ 473 M | ||
|
Koninklijke Philips N.V.
PHG
|
32 | $ 29.09 | 1.89 % | $ 20 B | ||
|
Guardant Health
GH
|
107 | $ 85.36 | 3.83 % | $ 10.7 B | ||
|
QIAGEN N.V.
QGEN
|
38.3 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
3.19 | $ 2.83 | -0.88 % | $ 91.8 K | ||
|
Biomerica
BMRA
|
3.13 | $ 2.1 | 0.96 % | $ 4.82 M | ||
|
ICON Public Limited Company
ICLR
|
201 | $ 112.78 | 2.18 % | $ 9.3 B | ||
|
Laboratory Corporation of America Holdings
LH
|
287 | $ 267.65 | 1.26 % | $ 22.3 B | ||
|
Senseonics Holdings
SENS
|
8.4 | $ 6.74 | 0.3 % | $ 281 M | ||
|
Celcuity
CELC
|
115 | $ 119.69 | -0.59 % | $ 5.6 B | ||
|
Soleno Therapeutics
SLNO
|
41 | $ 52.63 | -0.03 % | $ 2.67 B | ||
|
Neogen Corporation
NEOG
|
4.7 | $ 9.51 | 3.99 % | $ 2.06 B | ||
|
Lantheus Holdings
LNTH
|
75.9 | $ 82.78 | 1.35 % | $ 5.59 B | ||
|
Motus GI Holdings
MOTS
|
0.64 | - | -34.28 % | $ 263 K | ||
|
Invitae Corporation
NVTA
|
2.17 | - | - | $ 21.2 M | ||
|
Quest Diagnostics Incorporated
DGX
|
210 | $ 193.1 | 0.1 % | $ 21.4 B | ||
|
ENDRA Life Sciences
NDRA
|
4.65 | $ 5.07 | -2.41 % | $ 3.99 M | ||
|
Neuronetics
STIM
|
1.23 | $ 1.41 | 1.08 % | $ 93 M | ||
|
National Research Corporation
NRC
|
14.1 | $ 16.94 | 0.74 % | $ 379 M |